Applied Pharmacology:
Buprenorphine Formulations (And Equivalency Between Formulations)
Fudala PJ, Yu E, Macfadden W, Boardman C, and Chiang CN. Effects of buprenorphine and naloxone in morphine-stabilized opioid addicts. Drug and Alcohol Dependence (50):1–8, 1998.
Kuhlman JJ, Lalani S, Magluilo J, Levine B, Darwin WD, Johnson RE, and Cone EJ. Human pharmacokinetics of intravenous, sublingual, and buccal buprenorphine. Journal of Analytical Toxicology (20):369–378, 1996.
Mendelson J, Jones RT, Fernandez I, Welm S, Melby AK, and Baggott MJ. Buprenorphine and naloxone interactions in opiate-dependent volunteers. Clinical Pharmacology and Therapeutics (60):105–114, 1996.
Mendelson J, Upton RA, Everhart ET, Jacob P, and Jones RT. Bioavailability of sublingual buprenorphine. Journal of Clinical Pharmacy and Therapeutics (37):31–37, 1997.
Mendelson J, Jones RT, Welm S, Brown J, and Batki SL. Buprenorphine and naloxone interactions in methadone maintenance patients. Biological Psychiatry (41):1,095–1,101, 1997.
Mendelson J, Jones RT, Welm S, Baggott M, Fernandez I, Melby AK, and Nath RP. Buprenorphine and naloxone combinations: The effects of three dose ratios in morphine-stabilized, opiate-dependent volunteers. Psychopharmacology (141):37–46, 1999.
Nath RP, Upton RA, Everhart ET, Cheung P, Shwonek P, Jones RT, and Mendelson JE. Buprenorphine pharmacokinetics: Relative bioavailability of sublingual tablet and liquid formulations. Journal of Clinical Pharmacology (39):619–623, 1999.
Preston KL, Bigelow GE, and Liebson IA. Buprenorphine and naloxone alone and in combination in opioid-dependent human volunteers. Psychopharmacology (94):484–490, 1988.
Schuh KJ and Johanson CE. Pharmacokinetic comparison of the buprenorphine sublingual liquid and tablet. Drug and Alcohol Dependence (56):55–60, 1999.
Strain EC, Walsh SL, Preston KL, Liebson IA, and Bigelow GE. The effects of buprenorphine in buprenorphine-maintained volunteers. Psychopharmacology (129):329–338, 1997.
Strain EC, Stoller K, Walsh SL, and Bigelow GE. Effects of buprenorphine versus buprenorphine/naloxone tablets in non-dependent opioid abusers. Psychopharmacology (148):374–383, 2000.
Weinberg DS, Inturrisi CE, Reidenberg B, Moulin DE, Nips TJ, Wallenstein S, Houde RW, and Foley KM. Sublingual absorption of selected opioid analgesics. Clinical Pharmacology and Therapeutics (44):335–342, 1988.
Return to the table of contents.
|
